04066
Fmoc-5-Ava-OH
≥98.0% (HPLC)
别名:
5-(Fmoc-氨基)戊酸, 5-(芴甲氧羰基-氨基)戊酸
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C20H21NO4
化学文摘社编号:
分子量:
339.39
UNSPSC Code:
12352209
NACRES:
NA.26
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
3565625
Quality Level
assay
≥98.0% (HPLC)
form
powder
reaction suitability
reaction type: Fmoc solid-phase peptide synthesis
color
white
mp
137-145 °C
application(s)
peptide synthesis
functional group
Fmoc
storage temp.
2-8°C
SMILES string
OC(=O)CCCCNC(=O)OCC1c2ccccc2-c3ccccc13
InChI
1S/C20H21NO4/c22-19(23)11-5-6-12-21-20(24)25-13-18-16-9-3-1-7-14(16)15-8-2-4-10-17(15)18/h1-4,7-10,18H,5-6,11-13H2,(H,21,24)(H,22,23)
InChI key
ULLSWWGYZWBPHK-UHFFFAOYSA-N
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Wen Shi et al.
Biomaterials, 35(22), 5760-5770 (2014-04-24)
N-(2-hydroxypropyl)-methacrylamide (HPMA) copolymers have shown promise for application in the detection and staging of cancer. However, non-target accumulation, particularly in the liver and spleen, hinders the detection of resident or nearby metastatic lesions thereby decreasing diagnostic effectiveness. Our laboratory has
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| N3019-25G | 04061834115663 |
| N3405-100G | 04061834116059 |
| N3405-500G | 04061831836769 |
| 8410230100 | 04022536626154 |
| N3019-500G | 04061834115670 |
| 04066-1G | 04061838628787 |
| 04066-5G | 04061832593036 |